External quality assessment scheme for influenza virus detection, isolation and culture for the European Reference Laboratory Network for Human Influenza, 2013
In September/October 2013, the European Reference Laboratory Network for Human Influenza (ERLI-Net) conducted an external quality assessment (EQA) for the rapid detection of influenza virus, its isolation and culture.
Handbook on tuberculosis laboratory diagnostic methods in the European Union - Updated 2018
This handbook provides network members and other laboratories involved in the diagnosis of tuberculosis, with an agreed list of key diagnostic methods and their protocols in various areas of TB diagnosis.
External quality assessment scheme for Neisseria meningitidis - 2014
In July 2014, a panel of two viable isolates of N. meningitidis of the major disease-causing serogroups with three simulated cerebrospinal fluid (non-culture) samples for molecular studies, was sent by UK NEQAS to 30 reference laboratories in the IBD-labnet surveillance network for quality assessment testing. This report summarises the diagnostic results submitted by the participating laboratories.
External quality assessment scheme for Streptococcus pneumoniae – 2014
In July 2014, a panel of three strains of Streptococcus pneumoniae and two simulated samples of cerebrospinal fluid was sent to 30 reference laboratories in the IBD-labnet surveillance network for quality assessment testing. This report summarises the diagnostic results submitted by the participating laboratories.
Laboratory testing of non-partner sperm donors
The European Centre for Disease Prevention and Control was asked by the European Commission to assess the risk involved in changing the testing requirements for HIV (human immunodeficiency virus), hepatitis B virus (HBV), and hepatitis C virus (HCV) with regard to the quality and safety of non-partner semen donations.
First Worldwide Proficiency Study on Variable-Number Tandem-Repeat Typing of Mycobacterium tuberculosis Complex Strains
de Beer, J.L., Kremerb, K., Ködmön, C., Supplyd, P., van Soolingen, D., the Global Network for the Molecular Surveillance of Tuberculosis, 2009
Guidance for clinical and public health laboratories testing for influenza virus antiviral drug susceptibility in Europe
Pozo, F., Lina, B., Andrade, H.R., Enouf, V., Kossyvakis, A., Broberg, E., Daniels, R., Lackenby, A., Meijer, A.
Second worldwide proficiency study on variable number of tandem repeats typing of Mycobacterium tuberculosis complex
De Beer, J.L., Ködmon, C., Van Ingen, J., Supply, P., Van Soolingen, D., Jamieson, F.B., Bidovec-Stojkovic, U., Brown, T., Cirillo, D.M., Cruz, L., Mira, A., Dou, H.-Y., Fauville-Dufaux, M., Fitzgibbon, M.M., García De Viedma, D., Groenheit, R., Haanperä-Heikkinen, M., Indra, A., Kam, K.M., Kramer, R., Jiang, G.-L., Niemann, S., Obrovac, M., Rasmussen, E.M., Refrégier, G., Realpe, T., Samper, S., Sharma, M.K., Sougakoff, W., Stakenas, P., Stavrum, R., Trenkler, J., WaDa T., Siame, K.K., Tafaj, S., Cowan, L., Sng, L.-H., Seagar, A.-L., Basu, I., Rastogi, N., Ferro, B.E., de Matos, F., Kipnis, A., van Soolingen, D., Supply, P.
2015/16 I-MOVE/I-MOVE+ multicentre case control study in Europe: moderate vaccine effectiveness estimates against influenza A(H1N1)pdm09 and low estimates against lineage mismatched influenza B among children.
Kissling, E., Valenciano, M., Pozo, F., Vilcu, A.M., Reuss, A., Rizzo, C., Larrauri, A., Horvath, J.K., Brytting, M., Domegan, L., Korczynska, M., Meijer, A., Machado, A., Ivanciuc, A., Visekruna Vucina, V., van der Werf, S., Schweiger, B., Bella, A., Gherasim, A., Ferenczi, A., Zakikhany, K., O'Donnell, J., Paradowska-Stankiewicz, I., Dijkstra, F., Guiomar, R., Lazar, M., Kurecic Filipovic, S., Johansen, K., Moren, A., I-MOVE/I-MOVE+ study team
Aiming for zero tuberculosis transmission in low-burden countries
Marais, B.J., Walker, T.M., Cirillo, D.M., Raviglione, M., Abubakar, I., van der Werf, M.J., Boehme, C., Niemann, S., Castro, K.G., Zumla, A., Sintchenko, V., Crook, D.W.